Transforming lives and improving outcomes using noninvasive diagnostics for transplant and transfusion patients.
Personalized Post-Transplant MonitoringInternational Innovation
, "The Personalized Touch" Read Article
New Diagnostic Assay for Post-Transplant Monitoring
Blood Test Predicts Signs of Acute Rejection in Kidney Transplants Read Article
Immucor expands investment in Post-Transplant Monitoring
Immucor Acquires Organ-i Read Article
IMMUCOR has pioneered and led the development of reagents, testing, IT platforms, and the commercialization of transfusion and transplant diagnostic technologies. For more than 30 years we have been providing solutions to healthcare professionals in the fields of laboratory medicine and across several clinical areas benefiting physicians and patients across the globe.. We are excited to broaden our support to the clinical community through the launch of our IMMUCOR DX laboratory service.
IMMUCOR DX is very different from a routine clinical laboratory. The complex nature of immunology requires a team approach The laboratory service leverages IMMUCOR expertise and new technology to build upon legacy products to enhance the delivery of diagnostic solutions to our laboratory customers, clinicians and the patients they care for.
IMMUCOR DX is positioned to provide:
- Accelerated availability of novel technologies to laboratories, clinicians and patients.
- Improve access to clinicians and patients in areas where traditional laboratory IVD models or alternative products cannot support their unique circumstances.
- Support our laboratory customers by providing additional services such as extra capacity during periods of high demand or labor shortages, and conversion services
IMMUCOR DX will initially focus on improving access to special patient populations for post-transplant monitoring and red cell genotyping.